scholarly journals Long-term patient-reported outcome measures after injury: National Trauma Research Action Plan (NTRAP) scoping review protocol

2020 ◽  
Vol 5 (1) ◽  
pp. e000512
Author(s):  
Juan Pablo Herrera-Escobar ◽  
Manuel A Castillo-Angeles ◽  
Samia Y Osman ◽  
Claudia P Orlas ◽  
Mahin B Janjua ◽  
...  

BackgroundA significant proportion of patients who survive traumatic injury continue to suffer impaired functional status and increased mortality long after discharge. However, despite the need to improve long-term outcomes, trauma registries in the USA do not collect data on outcomes or care processes after discharge. One of the main barriers is the lack of consensus regarding the optimal outcome metrics.ObjectivesTo describe the methodology of a scoping review evaluating current evidence on the available measures for tracking functional and patient-reported outcomes after injury. The aim of the review was to identify and summarize measures that are being used to track long-term functional recovery and patient-reported outcomes among adults after injury.MethodsA systematic search of PubMed and Embase will be performed using the search terms for the population (adult trauma patients), type of outcomes (long-term physical, mental, cognitive, and quality of life), and measures available to track them. Studies identified will be reviewed and assessed for relevance by at least two reviewers. Data will be extracted and summarized using descriptive statistics and a narrative synthesis of the results. This protocol is being reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines.DisseminationThis scoping review will provide information regarding the currently available metrics for tracking functional and patient-reported outcomes after injury. The review will be presented to a multi-disciplinary stakeholder group that will evaluate these outcome metrics using an online Delphi approach to achieve consensus as part of the development of the National Trauma Research Action Plan (NTRAP). The results of this review will be presented at relevant national surgical conferences and published in peer-reviewed scientific journals.

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Deborah M. Stein ◽  
Maxwell A. Braverman ◽  
Jimmy Phuong ◽  
Edward Shipper ◽  
Michelle A. Price ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Nicole S. Gibran ◽  
Edward Shipper ◽  
Jimmy Phuong ◽  
Max Braverman ◽  
Pam Bixby ◽  
...  

2017 ◽  
Vol 82 (3) ◽  
pp. 637-645 ◽  
Author(s):  
Raul Coimbra ◽  
Rosemary A. Kozar ◽  
Jason W. Smith ◽  
Ben L. Zarzaur ◽  
Carl J. Hauser ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Craig D. Newgard ◽  
Maxwell A. Braverman ◽  
Jimmy Phuong ◽  
Edward S. Shipper ◽  
Michelle A. Price ◽  
...  

2018 ◽  
Vol 84 (6) ◽  
pp. 1012-1016 ◽  
Author(s):  
Eileen M. Bulger ◽  
Todd E. Rasmussen ◽  
Gregory J. Jurkovich ◽  
Timothy C. Fabian ◽  
Rosemary A. Kozar ◽  
...  

2021 ◽  
Vol 10 (9) ◽  
pp. 2009
Author(s):  
Joaquín Fernández ◽  
Manuel Rodríguez-Vallejo ◽  
Javier Martinez ◽  
Noemi Burguera ◽  
David P. Piñero

(1) Background: To evaluate the efficacy at 6 years postoperative after the implantation of a trifocal intraocular lens (IOL) AT Lisa Tri 839MP. The secondary objective was to evaluate the contrast sensitivity defocus curve (CSDC), light distortion analysis (LDA), and patient reported outcomes (PROs). (2) Methods: Sixty-two subjects participated in phone call interviews to collect data regarding a visual function questionnaire (VF-14), a patient reported spectacle independence questionnaire (PRSIQ), and questions related to satisfaction and decision to be implanted with the same IOL. Thirty-seven of these subjects were consecutively invited to a study visit for measurement of their visual acuity (VA), CSDC, and LDA. (3) Results: The mean monocular distance corrected VA was −0.05, 0.08, and 0.05 logMAR at far and distances of 67 cm and 40 cm, respectively. These VAs were significantly superior to those reported in previous literature (p < 0.05). The total area under the CSDC was 2.29 logCS/m−1 and the light distortion index 18.82%. The mean VF-14 score was 94.73, with 19.4% of subjects requiring spectacles occasionally for near distances, and 88.9% considering the decision of being operated again; (4) Conclusions: Long-term AT LISA Tri 839MP IOL efficacy results were equal or better than those reported 12 months postoperatively in previous studies. The spectacle independence and satisfaction rates were comparable to those reported in short-term studies.


2021 ◽  
Vol 50 ◽  
pp. 101897
Author(s):  
Ana Almeida ◽  
Teresa Martins ◽  
Lígia Lima

Author(s):  
Shannon B. Juengst ◽  
Lauren Terhorst ◽  
Andrew Nabasny ◽  
Tracey Wallace ◽  
Jennifer A. Weaver ◽  
...  

The purpose of our scoping review was to describe the current use of mHealth technology for long-term assessment of patient-reported outcomes in community-dwelling individuals with acquired brain injury (ABI). Following PRISMA guidelines, we conducted a scoping review of literature meeting these criteria: (1) civilians or military veterans, all ages; (2) self-reported or caregiver-reported outcomes assessed via mobile device in the community (not exclusively clinic/hospital); (3) published in English; (4) published in 2015–2019. We searched Ovid MEDLINE(R) < 1946 to 16 August 2019, MEDLINE InProcess, EPub, Embase, and PsycINFO databases for articles. Thirteen manuscripts representing 12 distinct studies were organized by type of ABI [traumatic brain injury (TBI) and stroke] to extract outcomes, mHealth technology used, design, and inclusion of ecological momentary assessment (EMA). Outcomes included post-concussive, depressive, and affective symptoms, fatigue, daily activities, stroke risk factors, and cognitive exertion. Overall, collecting patient-reported outcomes via mHealth was feasible and acceptable in the chronic ABI population. Studies consistently showed advantage for using EMA despite variability in EMA timing/schedules. To ensure best clinical measurement, research on post-ABI outcomes should consider EMA designs (versus single time-point assessments) that provide the best timing schedules for their respective aims and outcomes and that leverage mHealth for data collection.


2016 ◽  
Vol 31 (2) ◽  
pp. 861-871 ◽  
Author(s):  
Amin Madani ◽  
Petru Niculiseanu ◽  
Wanda Marini ◽  
Pepa A. Kaneva ◽  
Benjamin Mappin-Kasirer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document